Early treatment benefits of ropinirole prolonged release in Parkinson's disease patients with motor fluctuations (Q42167241)

From Wikidata

Jump to navigation Jump to search

scientific article published on May 2010

edit

Language	Label	Description	Also known as
English	Early treatment benefits of ropinirole prolonged release in Parkinson's disease patients with motor fluctuations	scientific article published on May 2010

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20461810

retrieved

17 October 2017

title

Early treatment benefits of ropinirole prolonged release in Parkinson's disease patients with motor fluctuations (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20461810

retrieved

17 October 2017

main subject

Parkinson's disease

1 reference

based on heuristic

inferred from title

author

Robert A Hauser

series ordinal

3

object named as

Robert A Hauser

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20461810

retrieved

17 October 2017

author name string

Bonnie P Hersh

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20461810

retrieved

17 October 2017

Nancy L Earl

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20461810

retrieved

17 October 2017

Mark Stacy

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20461810

retrieved

17 October 2017

language of work or name

English

0 references

publication date

1 May 2010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20461810

retrieved

17 October 2017

published in

Movement Disorders

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20461810

retrieved

17 October 2017

volume

25

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20461810

retrieved

17 October 2017

issue

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20461810

retrieved

17 October 2017

page(s)

927-931

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20461810

retrieved

17 October 2017

cites work

Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FMDS.23040

retrieved

21 January 2018

Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FMDS.23040

retrieved

21 January 2018

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FMDS.23040

retrieved

21 January 2018

Steady-state pharmacokinetic properties of a 24-hour prolonged-release formulation of ropinirole: results of two randomized studies in patients with Parkinson's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FMDS.23040

retrieved

21 January 2018

Identifiers

DOI

10.1002/MDS.23040

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20461810

retrieved

17 October 2017

PubMed publication ID

20461810

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20461810

retrieved

17 October 2017

ResearchGate publication ID

44591473

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42167241&oldid=1935100310"